Unitree Robotics closed its first trading day on the Shenzhen Stock Exchange with a market capitalization of 60.99 billion yuan, establishing what industry bankers and venture investors now call the pricing anchor for Chinese robotics IPOs through at least 2027. The Hangzhou-based company, which built its valuation on sales of quadruped robots rather than humanoid systems, priced shares at 150.80 yuan during a book-building process that attracted institutional demand from domestic semiconductor funds, autonomous vehicle manufacturers, and three state-backed advanced manufacturing investment vehicles. The offering gives Unitree an enterprise value roughly 4.2 times its trailing twelve-month revenue, a multiple that reflects investor appetite for companies with demonstrated production capacity and existing customer contracts rather than prototype-stage technology. Seven humanoid robot developers now preparing A-share or Hong Kong Stock Exchange filings must answer a question their investment bankers did not anticipate six months ago: why should a pre-revenue humanoid startup command a valuation anywhere near a company that shipped 47,000 robot units in fiscal 2025 and holds supply agreements with logistics operators across fourteen provinces.
DeepRobotics filed preliminary prospectus documents with the China Securities Regulatory Commission in March 2026, disclosing that its Lynx humanoid platform entered pilot production in November 2025 with an initial run of 120 units delivered to warehouse automation customers in Guangdong and Jiangsu. The Hangzhou company, which raised a 1.8 billion yuan Series C round in August 2025 at a pre-money valuation of 6.5 billion yuan, now confronts investor questions about whether its technology warrants even one-tenth of Unitree's public market capitalization given that Unitree demonstrated profitable unit economics on its Go2 quadruped by the third quarter of 2024. Leju Robotics, which operates pilot humanoid assembly lines in Shenzhen producing bipedal systems for electronics manufacturing applications, originally targeted a Hong Kong listing in the second quarter of 2026 but postponed the offering after early investor meetings surfaced concerns about hardware margins and the company's reliance on imported actuators from Japanese suppliers. DOBOT, AgiBot, and Zhongqing all disclosed in regulatory filings between April and June 2026 that they revised downward their IPO valuation targets by margins ranging from eighteen to thirty-two percent following Unitree's debut, with bankers citing the quadruped maker's proven business model as the new baseline against which all robotics offerings would be measured.
The valuation reset reflects structural differences between companies that solved manufacturing and supply chain challenges years ago versus developers still debugging prototype hardware in laboratory environments. Unitree achieved gross margins above forty percent on its quadruped robot sales by the fourth quarter of 2025, according to prospectus filings, by vertically integrating motor production and developing proprietary control algorithms that reduced per-unit compute costs. The company operates three factories in Zhejiang province with combined annual capacity exceeding 200,000 units and maintains direct relationships with Foxconn, BYD Electronics, and other contract manufacturers that provide volume discounts on commodity components. DeepRobotics, by contrast, disclosed in its prospectus that it recorded negative gross margins on pilot humanoid deliveries through the first quarter of 2026, with each Lynx unit sold at a loss as the company subsidizes early customer deployments to generate operational data and refine its design. AgiBot's regulatory filings show the company spent 340 million yuan on research and development in 2025 while generating just 28 million yuan in revenue from prototype sales and engineering services, a burn rate that makes comparisons to Unitree's profitability profile difficult to justify to public market investors.
X Square Robot, which emerged from a Tsinghua University research lab and raised a 450 million yuan Series A round in January 2026, represents the extreme end of the valuation pressure. The Beijing company demonstrated a humanoid prototype capable of autonomous stair climbing and object manipulation at the World Robot Conference in August 2025 but has yet to announce a single commercial customer or disclose production timelines for market-ready units. Investment bankers who worked on the company's initial IPO preparation told industry sources they advised X Square to delay public listing plans until at least the second half of 2027, when the company expects to complete construction of a pilot manufacturing facility in Tianjin with annual capacity of 5,000 units. The strategic calculus has shifted for Chinese humanoid developers who spent 2024 and early 2025 assuming public market investors would reward ambitious technology roadmaps and founder pedigrees with valuations comparable to American counterparts like Figure AI and Apptronik. Unitree's IPO established that Chinese equity markets, shaped by retail investor participation and regulatory scrutiny of unprofitable technology offerings, will instead demand evidence of manufacturing execution and unit economics before extending premium valuations to robotics companies regardless of their technical capabilities or founder credentials.
What to Watch: DeepRobotics must decide by September 2026 whether to proceed with its A-share IPO at a dramatically reduced valuation or pursue a later-stage private funding round that would give the company additional quarters to demonstrate margin improvement on humanoid sales. AgiBot's management team faces a board meeting in late August to address whether the company should pivot from an IPO strategy to a potential acquisition by a state-owned enterprise seeking robotics capabilities, with China Electronics Corporation and Siasun Robot & Automation reportedly conducting due diligence. Leju Robotics plans to disclose second-quarter 2026 financial results in mid-September, with particular attention on whether the company achieved positive gross margins on its bipedal manufacturing robots after implementing a redesigned actuator sourcing strategy that reduced reliance on imported components.
